OpenScience.ink

4 weeks ago • Obesity (Silver Spring, Md.)

How Drugs That Activate the Glucagon-Like Peptide-1 Receptor Affect Body Fat and MuscleGlucagon-Like Peptide-1 Receptor Agonist-Based Agents and Body Composition: Filling More Gaps.

🎖️ Top 10% Journal

4 weeks ago • Frontiers in immunology

How GLP-1 receptor activators may protect the brain and help treat neurological diseases by affecting metabolismGLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection.

🥉 Top 5% Journal

4 weeks ago • International journal of obesity (2005)

Use and Interest in GLP-1 Medications in a Representative Survey of FinnsGLP-1 medications: use and interest in a representative survey of Finns.

🎖️ Top 10% Journal

1 month ago • European heart journal open

Addiction as a heart and metabolism disease: a brain-heart-metabolism perspective and the growing role of GLP-1 receptor treatmentsAddiction as a cardiometabolic disease: a neurocardiometabolic framework and the emerging role of GLP-1 receptor therapies.

🎖️ Top 10% Journal

3 weeks ago • Journal of laparoendoscopic & advanced surgical techniques. Part A

Weight loss and health results of metabolic surgery compared to GLP-1 drug treatment in 14,548 patientsComparative Outcomes of Metabolic and Bariatric Surgery Versus GLP-1 Receptor Agonists: An Updated Systematic Review and Meta-Analysis of 14,548 Patients.

📖 Top 50% Journal

1 week ago • Obesity pillars

Improvement of pleasure loss symptoms in obese patients treated with tirzepatide: A report on three casesResolution of anhedonia-like symptoms in patients treated for obesity with tirzepatide: A three-case series.

📖 Top 20% JournalCase Reports

5 days ago • Endocrinology, diabetes & metabolism

Tirzepatide and SGLT2 Inhibitors for Heart Failure with Normal Pumping and Obesity: Moving Toward New Treatments for Heart and Metabolic HealthTirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era.

📖 Top 20% JournalArticle

6 days ago • Tobacco induced diseases

GLP-1 drugs for quitting smoking and managing weight after quitting: A review and combined analysis of clinical trialsGLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials.

📖 Top 30% JournalArticle

6 days ago • Frontiers in artificial intelligence

Using machine learning to predict blood sugar control and weight loss in people taking GLP-1 receptor drugsMachine learning algorithms for predicting glycemic control and weight loss outcomes in GLP-1 receptor agonist users.

📖 Top 20% JournalArticle

6 days ago • Journal of integrative neuroscience

Brain-Wide Connections of GLP1R Neurons in the Thalamic Reticular NucleusBrain-Wide Connectivity of GLP1R Neurons in the Thalamic Reticular Nucleus.

📖 Top 30% JournalArticle

6 days ago • Journal of computer-aided molecular design

Creating a stable peptide drug that activates three hormone receptorsDesign of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity.

📖 Top 50% JournalArticle

1 week ago • Current issues in molecular biology

Different Anti-Inflammatory Effects of Semaglutide and Tirzepatide in DiabetesDifferential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus.

📖 Top 30% JournalArticle

1 week ago • Brain sciences

Linagliptin reduces memory problems caused by ketamine and diazepam in miceLinagliptin, a Selective DPP-4 Inhibitor, Attenuates Ketamine- and Diazepam-Induced Deficits in Passive Avoidance Performance in Mice.

📖 Top 20% JournalArticle

1 week ago • Metabolites

Using GLP-1 Receptor Agonists as Additional Metabolic Treatment After Liver Cancer SurgeryThe Liver Left Behind: GLP-1 Receptor Agonists and the Prospect of Metabolic Adjuvant Therapy After HCC Resection.

📖 Top 20% JournalEditorial

1 week ago • Metabolites

Body Weight and Fat Changes in Children Using GLP-1 Medicine for Obesity: A Pilot StudyBody Composition Changes During GLP-1 Receptor Agonist Therapy in Pediatric Obesity: A Pilot Study.

📖 Top 20% JournalArticle

1 week ago • Endocrinology, diabetes & metabolism

Metabolic and blood sugar effects of Orforglipron, a GLP-1 receptor drug, in adults with and without diabetes: A combined analysis of clinical trialsMetabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials.

📖 Top 20% Journal

1 week ago • Endocrinology, diabetes & metabolism

Effectiveness and safety of Tirzepatide for obesity in Asian and non-Asian adults without diabetesComparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

📖 Top 20% Journal

1 week ago • Journal of the Endocrine Society

Can genetic differences in GLP-1 and GIP receptors affect response to incretin therapy?Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?

📖 Top 20% Journal

1 week ago • Frontiers in neurology

GLP-1 receptor drugs may improve movement and mood in Parkinson's disease: a combined analysisGLP-1 receptor agonists in Parkinson's disease: a meta-analysis revealing motor benefit and highlighting mood improvement.

📖 Top 20% Journal

2 weeks ago • Rheumatology international

GLP-1 receptor drugs in joint and psoriatic diseases: a possible connection between obesity and inflammationGLP-1 receptor agonists in osteoarthritis and psoriatic disease: the missing link between obesity and inflammation?

📖 Top 20% Journal

3 weeks ago • BMC gastroenterology

Effects of Glucagon-like Peptide-1 Drugs on Pancreas Health in Chronic Pancreatitis PatientsGlucagon-like peptide-1 receptor agonists and pancreatic outcomes in chronic pancreatitis: a real-world cohort study.

📖 Top 30% Journal

3 weeks ago • Diagnostics (Basel, Switzerland)

Can Fasting Levels of GLP-1 and GIP Predict How Well People Initially Respond to Semaglutide and Tirzepatide?Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide?

📖 Top 30% Journal

3 weeks ago • Diagnostics (Basel, Switzerland)

Tracking Bone Loss During GLP-1RA Treatment Using a Urine Test for Bone BreakdownTracking Bone Loss in GLP-1RA Therapy: The Potential of the Deoxypyridinoline Urine Test.

📖 Top 30% Journal

3 weeks ago • Molecular brain

Semaglutide changes behavior and activity in the brain's reward system in healthy miceSemaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.

📖 Top 20% Journal

4 weeks ago • Frontiers in clinical diabetes and healthcare

Time-limited eating in adults with type 2 diabetes taking GLP-1 diabetes medications: case reportTime-restricted eating in adults with type 2 diabetes mellitus on concomitant glucagon-like peptide-1 receptor agonists: case report.

📖 Top 30% Journal

4 weeks ago • Frontiers in bioscience (Landmark edition)

Semaglutide changes fat metabolism in internal belly fat of mice with type 2 diabetesSemaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study.

📖 Top 30% Journal

1 month ago • Biomolecular concepts

Recent advances in the molecules, genes, and treatments of type 2 diabetes (2015-2025)Molecular, genetic, and pharmacological advances in type 2 diabetes (2015-2025).

📖 Top 50% Journal

2 days ago • Global cardiology science & practice

Incretin therapies and PPARγ activators as regulators of fat hormone and antioxidant pathways in diabetes-related heart diseaseIncretin-based therapies and PPARγ agonists as regulators of adipokines-Nrf2 axis in diabetic cardiovascular disease.

📖 Top 50% JournalArticle

1 week ago • Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Comparing lifestyle changes, surgery, and semaglutide for weight control in endometrial cancerComparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.

📖 Top 50% Journal

2 weeks ago • The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Glucagon-like peptide-1 receptor drugs and their effects in heart attack patients: a combined review and analysisA systematic review and meta-analyses of glucagon-like peptide-1 receptor agonists in acute myocardial infarction.

📖 Top 50% Journal

← prevpage 4 of 14next →

GLP-1 Therapies Research Papers